Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Analyst opinion has improved significantly over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company has insufficient levels of profitability.

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.